Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medacta Group SA
  6. News
  7. Summary
    MOVE   CH0468525222


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Medacta : Announces Successful Completion of First Reverse Shoulder Arthroplasties using NextAR Augmented Reality Surgical Platform Read More >

07/14/2021 | 01:07pm EDT

Media Release

Medacta Announces Successful Completion of First Reverse Shoulder Arthroplasties using NextAR Augmented Reality Surgical Platform

Game-changing innovation allowed surgeons to precisely replicate preoperative planning, while maintaining closer focus on their patients for improved accuracy and efficiency

CASTEL SAN PIETRO, 14 July 2021 - Medacta announced today the successful completion of the first Reverse Shoulder Arthroplasty (RSA) surgeries utilizing its NextARTM Shoulder, the first CE-marked and FDA-cleared Augmented Reality surgical application with intraoperative guidance for total shoulder replacement.

NextAR Shoulder is designed to improve efficiency and precision in total shoulder replacement, while supporting the advancement of personalized surgery. Prof. Dr. med. Matthias Zumstein and John-Erik Bell, M.D., have performed the first European and U.S. surgeries utilizing NextAR Shoulder at the Engeriedspital in Bern, Switzerland and the Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, New Hampshire, respectively.

'Having just completed the first case using NextAR Shoulder worldwide, I can say that this is truly a great innovation in shoulder arthroplasty,' says Prof. Zumstein, who serves as Section Head Shoulder, Elbow and Orthopaedic Sports Medicine at Orthopädie Sonnenhof in Bern and has collaborated with Medacta on the development of NextAR Shoulder. 'The intraoperative guidance helped me to perform a more accurate implant positioning and the Augmented Reality allowed me to stay focused on the surgical field. Never before have I been able to stick so closely to my preoperative planning.'

Prior to surgery, the surgeon uses a 3D virtual model of the patient's shoulder to choose the best implant and position to restore the patient's unique anatomy. NextAR Shoulder enhances the preoperative implant-bone preparation with unique intraoperative orientation assessments, allowing surgeons to track real-time positioning.

During the operation, the surgeon uses the NextAR Smart Glasses to visualize surgical actions and information in real-time, directly on the operative field. This ensures that all adjustments are based on real-time data and enables the surgeon to remain focused on the patient for an optimal user experience. With this process, the NextAR Shoulder platform allows for exceptional precision and control, ultimately translating to enhanced efficiency in the operating room.

'Performing my first augmented reality-assisted total shoulder replacement using Medacta's NextAR Shoulder was really exciting,' says Dr. Bell, orthopaedic surgeon at DHMC and an associate professor of orthopaedic surgery at the Geisel School of Medicine at Dartmouth with more than 21 years of experience in the medical field. 'This was a powerful use of new technology to improve patient care because it allowed me to precisely execute the three-dimensional preoperative plan I customized for my patient's unique anatomy. The intraoperative guidance allowed me to perform more accurate implant positioning, while the Augmented Reality let me to stay focused on the surgical field throughout the case.'

NextAR is the first platform to offer Augmented Reality solutions for both joint replacement and spine procedures. In line with Medacta's philosophy of healthcare sustainability, a single hardware with limited capital investment and low per-case disposable cost will be able to host diverse software, with additional economic benefits for the healthcare systems.

The NextAR surgical platform is part of Medacta's MySolutions ecosystem. Together with a comprehensive portfolio of implants and surgical techniques, MySolutions empowers Medacta's holistic approach to personalized medicine, aiming to bring value to every step of the patient journey from preoperative through postoperative care.

For more information about the NextAR Platform, please visit nextar.medacta.com.

Medacta International SA
Gianluca Olgiati
Senior Director Global Marketing
Phone: +41 91 696 60 60


About Medacta
Medacta is an international company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine. Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta's innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 40 countries.


Medacta Group SA published this content on 14 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 July 2021 17:06:02 UTC.

© Publicnow 2021
All news about MEDACTA GROUP SA
09/16MEDACTA : celebrates the milestone of 10,000 Medacta Shoulder System implanted w..
09/14MEDACTA : Credit Suisse Lifts Price Target on Medacta Group, Maintains Neutral R..
09/10MEDACTA : Swiss Medical Device Maker Medacta's H1 Profit Climbs as All Business ..
09/10MEDACTA : reports strong profitability with 31.9% adjusted EBITDA margin in the ..
09/10MEDACTA : Press Release – 2021 Half-Year Results
09/10MEDACTA : 2021 Half-Year Report
09/10MEDACTA : 2021 Half-Year Presentation
09/10Medacta reports strong profitability -2-
09/10Medacta reports strong profitability with 31.9% adjusted EBITDA margin in the..
09/10Medacta Group SA Confirms Revenue Guidance for the Year 2021
More news
Analyst Recommendations on MEDACTA GROUP SA
More recommendations
Sales 2021 348 M 408 M 408 M
Net income 2021 56,0 M 65,7 M 65,7 M
Net Debt 2021 83,5 M 97,9 M 97,9 M
P/E ratio 2021 49,7x
Yield 2021 0,54%
Capitalization 2 783 M 3 270 M 3 263 M
EV / Sales 2021 8,24x
EV / Sales 2022 7,15x
Nbr of Employees 1 246
Free-Float 30,5%
Duration : Period :
Medacta Group SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDACTA GROUP SA
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 4
Last Close Price 139,16 €
Average target price 107,02 €
Spread / Average Target -23,1%
EPS Revisions
Managers and Directors
Francesco Siccardi Chief Executive Officer
Corrado Farsetta Chief Financial Officer
Alberto Siccardi Executive Chairman
Victor Waldemar Balli Lead Independent Non-Executive Director
Philippe A. Weber Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC10.72%174 552